Revolutionizing Hair Loss Treatment: The Androgenetic Alopecia Market Opportunity
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEimLOerPVVpbIK5y3jvj11XHH_0Un4bQSNLvElFKZYRexNeQ5glyZ6IrjGrbRb3YgBDrTsVBkxgFG64Be8d-LSRJFs7Bu8KxxSe2paad4cxkLh5tS6Yd4kchyfZvvXmuCLcHj3qQtOjSOKIiSlZg1_zj13X7FQQ5DJb3Ggn6z1ueBO8_yvQg-j8wpiM/s320/androgenetic-alopecia-treatment-outlook.png)
A hereditary disease called androgenetic alopecia is brought on by an overreaction to androgens. This disorder, which can affect up to 50% of both sexes, is characterized by the progressive loss of scalp-level terminal hair at any point after puberty. Androgenetic alopecia is the typical cause of hair loss in both men and women, according to Asadi (2020). As per the DelveInsight assessment, the total number of prevalent cases of androgenetic alopecia was more than 194 million in the 7MM in 2021. The highest number of cases was seen in EU4 and the UK. Assessments showed that it affected about 50 million men and 30 million women in the United States; it begins in early adolescence and progresses with age. Additionally, more than 50% of men over 50 experience hair loss, whereas, in women, hair loss is more likely to occur after menopause. Social Stigma Related to Androgenetic Alopecia Hair plays a significant role in one's self-perception in today's society; as a result, hair lo